Transplant News and Research

RSS

University of Illinois receives Friends of Mel Foundation support grant for Bone Marrow Transplant Program

The University of Illinois is set to receive a grant from the Friends of Mel Foundation (FOM) in support of their Bone Marrow Transplant Program. The program was selected as the recipient of the Mel's Magic award for January 2011. Mel's Magic was created by FOM in May 2009 to familiarize their supporters with other organizations that work tirelessly to make a difference in the cancer community.

14 Jan 2011

Kidney transplant failure patients can opt for home-based dialysis therapy

According to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology, despite complications, these patients can choose to undergo dialysis in the comfort of their own homes.

14 Jan 2011

FDA asks manufacturers to eliminate higher-dose prescription combination acetaminophen products

The U.S. Food and Drug Administration is asking manufacturers of prescription combination products that contain acetaminophen to limit the amount of acetaminophen to no more than 325 milligrams in each tablet or capsule.

14 Jan 2011

Viewpoints: Health law repeal; Individual mandate; Essential benefits package; Arizona transplant program

If the government fails, then costs will rise inexorably. Nothing in the law guarantees success: The law embodies almost every idea anyone has offered and hopes a couple of them will work.

14 Jan 2011

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Transplanting their own bone marrow-derived stem cells into 48 patients with end-stage liver disease resulted in therapeutic benefit to a high number of the patients, report researchers publishing in the current issue of Cell Transplantation. Yet, the mechanism by which the infusion of CD34+ stem cells improves liver function remains elusive, they say.

11 Jan 2011

Genzyme provides update on discussions with Sanofi-Aventis

Genzyme Corp. (NASDAQ: GENZ) reported today that discussions between its financial advisors and financial advisors for Sanofi-Aventis are continuing and have expanded to include representatives of both companies.

11 Jan 2011

Roundup: Okla.'s health reform lawsuit; Medicaid issues draw attention in Texas, N.Y., N.J.

Gov. Andrew Cuomo's alliance with the state's health-care union and hospital lobby is drawing fire from some patient advocates, who question the governor's decision to give the powerful industry figures a front-and-center role in the process of overhauling Medicaid (Gershman, 1/8).

10 Jan 2011

Sangamo completes enrollment in SB-509-901 Phase 2b clinical trial in diabetic neuropathy

Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.

10 Jan 2011

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that patient enrollment has begun in a multicenter, open-label clinical study of CMX001 (the CMX001-350 study) for the treatment of life-threatening or serious conditions caused by double-stranded DNA (dsDNA) viruses.

7 Jan 2011

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).

7 Jan 2011

Roundup: In Oregon, New Gov. Kitzhaber vows to change state's health care delivery system; In Ariz., 2nd person denied transplant coverage dies

Oregon Governor-elect John Kitzhaber, a Democrat who will be inaugurated in Salem on Monday (January 10), is no stranger to the state's top political office: He was a two-term governor between 1995 and 2003. ... An emergency-room physician by background, Kitzhaber, 62, also is no stranger to the nation's health care system, which he sees as costly, ineffective and unsustainable.

7 Jan 2011

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

LifeCycle Pharma A/S has announced positive top-line results from a Phase 2 clinical trial involving 58 patients comparing LCP-Tacro™ tablets administered once-daily versus Prograf® (tacrolimus) capsules (Astellas Pharma) administered twice-daily in de novo liver transplant patients for one year.

7 Jan 2011

Athersys completes patient enrollment in MultiStem Phase I study for leukemia

Athersys, Inc. today announced that it has completed patient enrollment of the single dose arm of a clinical study involving administration of MultiStem to patients being treated for leukemia or other blood born cancers.

7 Jan 2011

Liver transplant recipients develop PTMS, face high risk of cardiovascular disease

Researchers from Israel have determined that more than half of liver transplant recipients develop post-transplantation metabolic syndrome, placing them at greater risk for cardiovascular disease.

7 Jan 2011

Robo4 molecule may improve bone marrow transplants: Study

Researchers at the University of California, Santa Cruz, have identified a key molecule for establishing blood stem cells in their niche within the bone marrow. The findings, reported in the January issue of Cell Stem Cell, may lead to improvements in the safety and efficiency of bone marrow transplants.

7 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

Kiadis Pharma, Hospira sign license agreement to develop and commercialize ATIR hematology product

Kiadis Pharma, a biopharmaceutical company based in The Netherlands, announced that it has entered into a licensing agreement with Hospira, Inc., a global specialty pharmaceutical company, to develop and commercialize Kiadis Pharma's ATIR™.

5 Jan 2011

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.

4 Jan 2011

New ATS guidelines for treating fungal infection in adult pulmonary and critical care patients

The American Thoracic Society has released a new official clinical policy statement on the treatment of fungal infections in adult pulmonary and critical care patients.

4 Jan 2011

Florida public hospitals a likely target for new governor; Two people appointed to create Calif. health exchange

Florida's government-owned hospitals will be in the political cross hairs after Tuesday's inauguration of Rick Scott, once leader of the nation's largest for-profit hospital chain. The governor-elect's transition team has recommended creation of a panel to study whether government-owned hospitals -- Miami-Dade's Jackson Health System and Broward's two hospital districts among them -- are necessary (Dorschner, 1/2).

4 Jan 2011

Transplant News and Research

University of Illinois receives Friends of Mel Foundation support grant for Bone Marrow Transplant Program

Kidney transplant failure patients can opt for home-based dialysis therapy

FDA asks manufacturers to eliminate higher-dose prescription combination acetaminophen products

Viewpoints: Health law repeal; Individual mandate; Essential benefits package; Arizona transplant program

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Genzyme provides update on discussions with Sanofi-Aventis

Roundup: Okla.'s health reform lawsuit; Medicaid issues draw attention in Texas, N.Y., N.J.

Sangamo completes enrollment in SB-509-901 Phase 2b clinical trial in diabetic neuropathy

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Roundup: In Oregon, New Gov. Kitzhaber vows to change state's health care delivery system; In Ariz., 2nd person denied transplant coverage dies

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

Athersys completes patient enrollment in MultiStem Phase I study for leukemia

Liver transplant recipients develop PTMS, face high risk of cardiovascular disease

Robo4 molecule may improve bone marrow transplants: Study

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Kiadis Pharma, Hospira sign license agreement to develop and commercialize ATIR hematology product

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

New ATS guidelines for treating fungal infection in adult pulmonary and critical care patients

Florida public hospitals a likely target for new governor; Two people appointed to create Calif. health exchange

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News